http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100365291-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
| filingDate | 2000-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100365291-B1 |
| titleOfInvention | An agent for preventing development of alcoholic fatty liver comprising an active substance derived from silk fibroin |
| abstract | The present invention relates to an alcoholic fatty liver formation preventive agent comprising silk fibroin as an active ingredient, and more particularly, to forming alcoholic fatty liver containing silk fibroin of low molecular weight which can be ingested into the human body by refining treatment and hydrolysis. It is about a preventive agent. Silk fibroin is a protein that can be obtained from cocoon and consists of 18 kinds of amino acids such as glycine, alanine, tyrosine, etc. This silk fibroin has excellent biocompatibility and has been used as cosmetic raw material, medical suture, bio material, and diabetes treatment agent from the past. Has been. However, there is no known or verified whether such silk fibroin has a protective effect against alcoholic fatty liver. The present invention finds and demonstrates that can be used as an active ingredient of alcoholic fatty liver formation preventive agent, and is an invention for a new use of silk fibroin. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020141778-A1 |
| priorityDate | 2000-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 517.